md afjalus siraj
Yale University
New Haven, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
Yale University
New Haven, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
University of Florida
Gainesville, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
The University of Hong Kong
Pokfulam, Hong Kong, SAR China
Review Editor
Pharmacology of Anti-Cancer Drugs
School of Medicine, Indiana University Bloomington
Indianapolis, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
Indiana University
Bloomington, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
The Netherlands Cancer Institute (NKI)
Amsterdam, Netherlands
Review Editor
Pharmacology of Anti-Cancer Drugs
University of Turin
Turin, Italy
Review Editor
Pharmacology of Anti-Cancer Drugs
University of Sharjah
Sharjah, United Arab Emirates
Review Editor
Pharmacology of Anti-Cancer Drugs
Northwest University
Xi'an, China
Review Editor
Pharmacology of Anti-Cancer Drugs
Zhengzhou University
Zhengzhou, China
Review Editor
Pharmacology of Anti-Cancer Drugs
Shenyang Pharmaceutical University
Shenyang, China
Review Editor
Pharmacology of Anti-Cancer Drugs
Wexner Medical Center, The Ohio State University
Columbus, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
Human Genome Sequencing Center, Baylor College of Medicine
Houston, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
University of Zurich
Zürich, Switzerland
Review Editor
Pharmacology of Anti-Cancer Drugs
Shenzhen Key Laboratory of Cardiovascular Disease, Fuwai Hospital Chinese Academy of Medical Sciences
Shenzhen, China
Review Editor
Pharmacology of Anti-Cancer Drugs
Dr Shroff Charity Eye Hospital.
Delhi, India
Review Editor
Pharmacology of Anti-Cancer Drugs